Financial Information

Latest Financial Results

Quarter Ended September 30, 2023

Financial Statements

Past Financial Results

2023

Quarter Ended June 30, 2023

Financial Statements

Quarter Ended March 31, 2023

Financial Statements

2022

Year Ended December 31, 2022

Quarter Ended September 30, 2022

Quarter Ended June 30, 2022

Quarter Ended March 31, 2022

Financial Statements

Financial Statements

Financial Statements

Financial Statements

2021

Year Ended December 31, 2021

Quarter Ended September 30, 2021

Quarter Ended June 30, 2021

Quarter Ended March 31, 2021

Financial Statements

Financial Statements

Financial Statements

Financial Statements

2020

Year Ended December 31, 2020

Quarter Ended September 30, 2020

Quarter Ended June 30, 2020

Quarter Ended March 31, 2020

Financial Statements

Financial Statements

Financial Statements

Financial Statements

2019

Year Ended December 31, 2019

Quarter Ended September 30, 2019

Quarter Ended June 30, 2019

Quarter Ended March 31, 2019

Financial Statements

Financial Statements

Financial Statements

Financial Statements

2018

Year Ended December 31, 2018

Quarter Ended September 30, 2018

Quarter Ended June 30, 2018

Financial Statements

Financial Statements

Financial Statements

Additional Documents

SEDAR Regulatory Filings

Year Ended December 31, 2022

NervGen (TSX-V: NGEN, OTCQX: NGENF) is a clinical stage biotech company dedicated to developing innovative treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. NervGen’s lead drug candidate, NVG-291, is being evaluated in a Phase 1b/2a clinical trial. The company’s lead target indication is spinal cord injury.

Contact

2955 Virtual Way
Suite 480
Vancouver, BC V5M 4X6

Phone: (778) 731-1711
Email: info@nervgen.com

Subscribe for Updates

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others